FULCRUM THERAPEUTICS, INC. (FULC) Operating income 2018–2025
FULCRUM THERAPEUTICS, INC. (FULC) annual operating income history from SEC filings — each fiscal year as reported.
-$84.8MFY2025 · since FY2018: -$33.5M → -$84.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.8M | -287.1% |
| FY2024 | -$21.9M | +80.2% |
| FY2023 | -$110.7M | +1.7% |
| FY2022 | -$112.6M | -38.9% |
| FY2021 | -$81.1M | -13.2% |
| FY2020 | -$71.6M | +15.0% |
| FY2019 | -$84.2M | -151.4% |
| FY2018 | -$33.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FULC financial trends
FULC RevenueFULC Net incomeFULC Net marginFULC Gross profitFULC Gross marginFULC Operating marginFULC Operating cash flowFULC Free cash flowFULC Capital expendituresFULC Return on equityFULC Stock buybacksFULC Dividends paidFULC Total assetsFULC Total liabilitiesFULC Shareholders’ equityFULC overview →